Published in J Virol on May 01, 1995
Role of the DIS hairpin in replication of human immunodeficiency virus type 1. J Virol (1996) 2.87
Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). J Virol (1996) 2.30
Primer tRNAs for reverse transcription. J Virol (1997) 1.90
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89
Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs. Nucleic Acids Res (2012) 1.66
The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure. RNA (2000) 1.63
Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J Virol (1997) 1.60
Structural basis for the specificity of the initiation of HIV-1 reverse transcription. EMBO J (1999) 1.59
Effects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 1.42
tRNA fragments in human health and disease. FEBS Lett (2014) 1.41
The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. J Virol (1997) 1.37
Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J Virol (1999) 1.37
Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J Virol (1999) 1.35
Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res (2011) 1.32
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol (1998) 1.25
The bipartite structure of the tRNA m1A58 methyltransferase from S. cerevisiae is conserved in humans. RNA (2005) 1.14
Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His). J Virol (1997) 1.11
A preferred region for recombinational patch repair in the 5' untranslated region of primer binding site-impaired murine leukemia virus vectors. J Virol (1996) 1.10
Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys). Nucleic Acids Res (1996) 1.10
Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex. Nucleic Acids Res (1998) 1.08
Forced evolution of a regulatory RNA helix in the HIV-1 genome. Nucleic Acids Res (1997) 1.07
Inhibition of human immunodeficiency virus type 1 replication with artificial transcription factors targeting the highly conserved primer-binding site. J Virol (2006) 1.07
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J Virol (1999) 1.06
Essential regions of the tRNA primer required for HIV-1 infectivity. Nucleic Acids Res (2000) 1.04
The nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro. Proc Natl Acad Sci U S A (1997) 1.04
Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol (1997) 1.03
Interactions between Ty1 retrotransposon RNA and the T and D regions of the tRNA(iMet) primer are required for initiation of reverse transcription in vivo. Mol Cell Biol (1998) 1.03
A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome. J Virol (2000) 1.02
Hairpin-induced tRNA-mediated (HITME) recombination in HIV-1. Nucleic Acids Res (2006) 0.97
The primer binding site on the RNA genome of human and simian immunodeficiency viruses is flanked by an upstream hairpin structure. Nucleic Acids Res (1997) 0.97
Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G. J Virol (2009) 0.95
Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS. RNA (2002) 0.93
Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis. J Virol (2003) 0.93
Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication. J Virol (2003) 0.92
The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles. Retrovirology (2011) 0.90
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res (1997) 0.89
The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. J Virol (1997) 0.88
Identification of critical elements in the tRNA acceptor stem and T(Psi)C loop necessary for human immunodeficiency virus type 1 infectivity. J Virol (2001) 0.88
Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1. J Virol (1997) 0.88
Defective replication in human immunodeficiency virus type 1 when non-primers are used for reverse transcription. J Virol (2005) 0.88
Initiation of HIV Reverse Transcription. Viruses (2010) 0.85
The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome. PLoS One (2014) 0.85
Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNA3Lys rather than tRNA1,2Lys. J Virol (1998) 0.84
Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses. J Virol (1999) 0.84
A succession of mechanisms stimulate efficient reconstituted HIV-1 minus strand strong stop DNA transfer. Biochemistry (2009) 0.83
Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans. J Virol (2006) 0.83
Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells. Retrovirology (2005) 0.82
Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides. Retrovirology (2015) 0.81
Impact of forced selection of tRNAs on HIV-1 replication and genome stability highlight preferences for selection of certain tRNAs. Virus Res (2006) 0.81
Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer. Nucleic Acids Res (2003) 0.80
In virio SHAPE analysis of tRNA(Lys3) annealing to HIV-1 genomic RNA in wild type and protease-deficient virus. Retrovirology (2015) 0.80
Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers. J Virol (2001) 0.80
A short sequence motif in the 5' leader of the HIV-1 genome modulates extended RNA dimer formation and virus replication. J Biol Chem (2014) 0.79
Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication. Nucleic Acids Res (2000) 0.78
On the primer binding site mutation that appears and disappears during HIV and SIV replication. Retrovirology (2015) 0.77
Mapping the small RNA content of simian immunodeficiency virions (SIV). PLoS One (2013) 0.77
Nucleotides within the anticodon stem are important for optimal use of tRNA(Lys,3) as the primer for HIV-1 reverse transcription. Virology (2007) 0.77
HIV-1 designed to use different tRNAGln isoacceptors prefers to select tRNAThr for replication. Virol J (2006) 0.77
New insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3. Retrovirology (2013) 0.76
Importance of A-loop complementarity with tRNAHis anticodon for continued selection of tRNAHis as the HIV reverse transcription primer. Virol J (2007) 0.76
An intact U5-leader stem is important for efficient replication of simian immunodeficiency virus. J Virol (2001) 0.76
Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors. Gene Ther (2016) 0.75
Analysis of the replication of HIV-1 forced to use tRNAMet(i) supports a link between primer selection, translation and encapsidation. Retrovirology (2007) 0.75
Forced selection of tRNA(Glu) reveals the importance of two adenosine-rich RNA loops within the U5-PBS for SIV(smmPBj) replication. Virology (2007) 0.75
A Fourth Generation Lentiviral Vector: Simplifying Genomic Gymnastics. Mol Ther (2017) 0.75
Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol (1987) 66.52
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52
Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell (1989) 6.28
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology (1991) 5.54
Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J (1988) 5.43
HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. EMBO J (1989) 4.73
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J Virol (1993) 3.08
Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol (1992) 3.06
Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem (1993) 2.95
Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J Virol (1994) 2.94
Reverse transcriptase as the major determinant for selective packaging of tRNA's into Avian sarcoma virus particles. J Virol (1980) 2.42
Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol (1994) 2.37
Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol (1986) 2.33
A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol (1994) 2.07
Deletions in the tRNA(Lys) primer-binding site of human immunodeficiency virus type 1 identify essential regions for reverse transcription. J Virol (1991) 1.97
Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay. Proc Natl Acad Sci U S A (1992) 1.88
Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly. J Virol (1981) 1.66
Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res (1993) 1.61
Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J Virol (1994) 1.56
Retrovirus-mediated insertion of expressed and non-expressed genes at identical chromosomal locations. Nucleic Acids Res (1993) 1.55
Mutated primer binding sites interacting with different tRNAs allow efficient murine leukemia virus replication. J Virol (1993) 1.50
In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res (1993) 1.44
Reverse transcriptase mediated binding of primer tRNA to the viral genome. Nucleic Acids Res (1979) 1.42
Interaction of tryptophan tRNA and avian myeloblastosis virus reverse transcriptase: further characterization of the binding reaction. Biochemistry (1977) 1.39
Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. J Mol Biol (1992) 1.35
Variable tRNA content in HIV-1IIIB. Biochem Biophys Res Commun (1992) 1.34
Localization of a polynucleotide binding region in the HIV-1 reverse transcriptase: implications for primer binding. Biochemistry (1991) 1.14
Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells. FEBS Lett (1994) 1.02
Using iodinated single-stranded M13 probes to facilitate rapid DNA sequence analysis--nucleotide sequence of a mouse lysine tRNA gene. Nucleic Acids Res (1983) 0.96
Studies on primer binding of HIV-1 reverse transcriptase using a fluorescent probe. J Mol Biol (1994) 0.86
Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 4.66
Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol (1992) 4.39
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92
Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology (1992) 2.76
Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol (2000) 2.65
Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47
Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41
A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol (1999) 1.91
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91
Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1997) 1.91
Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89
Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J (1994) 1.74
Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem (2001) 1.71
Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem (1988) 1.68
Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61
Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res (1996) 1.59
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52
In vivo selection of randomly mutated retroviral genomes. Nucleic Acids Res (1993) 1.44
The nucleotide sequence of a segment of Trypanosoma brucei mitochondrial maxi-circle DNA that contains the gene for apocytochrome b and some unusual unassigned reading frames. Nucleic Acids Res (1983) 1.44
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun (2006) 1.43
Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther (2006) 1.42
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41
Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther (2008) 1.40
In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A (2001) 1.40
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology (1997) 1.39
Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int Immunol (1991) 1.36
The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res (1999) 1.36
Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31
A conserved hairpin structure predicted for the poly(A) signal of human and simian immunodeficiency viruses. Virology (1995) 1.31
Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis. Nucleic Acids Res (1994) 1.30
Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1997) 1.28
Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res (1997) 1.27
Natural variants of the HIV-1 long terminal repeat: analysis of promoters with duplicated DNA regulatory motifs. Virology (1992) 1.26
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol (1998) 1.25
Determination of the RNA secondary structure that regulates lysis gene expression in bacteriophage MS2. J Mol Biol (1987) 1.24
Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site. J Virol (1999) 1.22
Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem (1993) 1.22
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase. Biochim Biophys Acta (1999) 1.22
Mechanism of translational coupling between coat protein and replicase genes of RNA bacteriophage MS2. Nucleic Acids Res (1985) 1.20
Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions. J Mol Biol (1995) 1.20
Effect of the sequences upstream from the ribosome-binding site on the yield of protein from the cloned gene for phage MS2 coat protein. Gene (1983) 1.15
The dimer initiation site hairpin mediates dimerization of the human immunodeficiency virus, type 2 RNA genome. J Biol Chem (2001) 1.14
Inhibition of polyadenylation by stable RNA secondary structure. Nucleic Acids Res (1998) 1.14
HIV-1 reverse transcriptase discriminates against non-self tRNA primers. J Mol Biol (1996) 1.14
Inhibiting HIV-1 entry with fusion inhibitors. Curr Med Chem (2003) 1.13
Increased virus replication in mammalian cells by blocking intracellular innate defense responses. Gene Ther (2008) 1.08
Sequence variation of the human immunodeficiency virus primer-binding site suggests the use of an alternative tRNA(Lys) molecule in reverse transcription. J Gen Virol (1997) 1.07
Forced evolution of a regulatory RNA helix in the HIV-1 genome. Nucleic Acids Res (1997) 1.07
A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J Virol (1999) 1.06
Induction in chimpanzees of antibodies inhibiting receptor-mediated cell fusion by HIV glycoprotein. Viral Immunol (1989) 1.04
The first strand transfer during HIV-1 reverse transcription can occur either intramolecularly or intermolecularly. Virology (1998) 1.03
Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res (1995) 1.03
Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr (2007) 1.03
Human immunodeficiency virus uses tRNA(Lys,3) as primer for reverse transcription in HeLa-CD4+ cells. FEBS Lett (1994) 1.02
The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol (1995) 1.02
Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res (2001) 1.02
A structured RNA motif is involved in correct placement of the tRNA(3)(Lys) primer onto the human immunodeficiency virus genome. J Virol (2000) 1.02
HIV-1 evolves into a nonsyncytium-inducing virus upon prolonged culture in vitro. Virology (1999) 1.00
The role of the codon and the initiation factor IF-2 in the selection of N-blocked aminoacyl-tRNA for initiation. Eur J Biochem (1980) 1.00
Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription. Nucleic Acids Res (2000) 0.99
RNA interference: its use as antiviral therapy. Handb Exp Pharmacol (2006) 0.99
Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. J Gen Virol (1998) 0.99
Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential. AIDS (1999) 0.97
Intracellular analysis of in vitro modified HIV Tat protein. J Biol Chem (1994) 0.97
Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. J Biol Chem (1995) 0.97
The amino terminal half of the MS2-coded lysis protein is dispensable for function: implications for our understanding of coding region overlaps. EMBO J (1985) 0.97
Role of HIV-1 RNA and protein determinants for the selective packaging of spliced and unspliced viral RNA and host U6 and 7SL RNA in virus particles. Nucleic Acids Res (2011) 0.97
Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. J Biol Chem (1992) 0.96
Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect. Virology (2001) 0.96
Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site. AIDS Res Hum Retroviruses (2000) 0.96
The mechanism of actinomycin D-mediated inhibition of HIV-1 reverse transcription. Nucleic Acids Res (1998) 0.96
Inhibition of human immunodeficiency virus type 1 by RNA interference using long-hairpin RNA. Gene Ther (2006) 0.96
Revertants and pseudo-revertants of human immunodeficiency virus type 1 viruses mutated in the long terminal repeat promoter region. J Gen Virol (1995) 0.94
Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology (1998) 0.94
Autoregulatory lentiviral vectors allow multiple cycles of doxycycline-inducible gene expression in human hematopoietic cells in vivo. Gene Ther (2009) 0.94
On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. AIDS Res Hum Retroviruses (1998) 0.93
Reverse transcriptase fidelity and HIV-1 variation. Science (1997) 0.91
A competitive cell growth assay for the detection of subtle effects of gene transduction on cell proliferation. Gene Ther (2011) 0.89
Biased nucleotide composition of the genome of HERV-K related endogenous retroviruses and its evolutionary implications. J Mol Evol (1999) 0.89
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res (1997) 0.89
Replicating viral vectors as HIV vaccines Summary Report from IAVI Sponsored Satellite Symposium, International AIDS Society Conference, July 22, 2007. Biologicals (2008) 0.87
Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology (1996) 0.86
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. J Virol (2000) 0.86
In vitro studies on tRNA annealing and reverse transcription with mutant HIV-1 RNA templates. J Biol Chem (2000) 0.86
Translational interference at overlapping reading frames in prokaryotic messenger RNA. Gene (1985) 0.85
Electroporation of the HIV Tat trans-activator protein into cells. Anal Biochem (1993) 0.84
Formylmethionyl-tRNA binding to 30 S ribosomes programmed with homopolynucleotides and the effect of translational initiation factor 3. Biochim Biophys Acta (1986) 0.84
Antiviral strategies against human coronaviruses. Infect Disord Drug Targets (2007) 0.82
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site. J Virol (2001) 0.79
Similarity of chemokines charge and the V3 domain of HIV-1 env protein. Emerg Infect Dis (1998) 0.79
The fidelity of reverse transcription differs in reactions primed with RNA versus DNA primers. J Biomed Sci (1999) 0.79